Webinars and Sponsored Roundtables — Register Now

Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.

Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.

Webinar presenter Jeffrey Gregg, MD, University of Nevada

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.

Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Manage Subscription

To receive CAP TODAY magazine, please subscribe here.
For change of address, mail new information to: CAP TODAY Circulation, 325 Waukegan Road, Northfield, IL 60093-2750 or visit here.

Marketplace Directory

Urine preservative product, 10/15

Lab Sensor Solutions will partner with MarketLab to distribute T-Tracks, which tracks, in real time, the temperature and location of clinical samples in transit, preventing laboratory specimen spoilage and loss and ensuring regulatory compliance. T-Tracks data are delivered to lab personnel’s desktops, laptops, and mobile devices.

Specialty matrix product line, 10/15

UTAK Laboratories released its SMx (specialty matrix) Product Line. SMx bulk matrices and quality control products are now offered as SMx Oral Fluid, SMx Sweat, SMx Hair, SMx Urine, SMx Serum, SMx Cerebral Spinal Fluid, and SMx Synovial Fluid.

Human whole-genome sequencing solution, 10/15

Illumina launched Illumina SeqLab, an integrated solution for customers with HiSeq X Systems designed to increase laboratory efficiency for population-scale, human whole-genome sequencing.

Ebola rapid diagnostic test receives FDA EUA, 10/15

OraSure Technologies received FDA Emergency Use Authorization for its OraQuick Ebola Rapid Antigen Test, which is designed to detect viral antigens in fingerstick and venous whole blood from patients presenting with signs and symptoms of Ebola infection in conjunction with epidemiological risk factors.

Rabbit monoclonal antibodies for IHC, 10/15

Bio SB announced a new line of rabbit monoclonal antibodies, SOX-10–RMab, for immunohistochemistry with extensive protein immunogenicity analysis of targeted epitopes, high sensitivity specificity, and low background noise.

Lab certification management, 10/15

LabRight Certification, from Vacava, is a tool for lab professionals that automates lab certification and accreditation management and aims to increase efficiency and lower operating costs by eliminating paperwork.

Multisystem integration for LIMS, 9/15

MedCompGx, a division of MedComp Sciences, announced the installation and implementation of UniConnect’s Precision MDx laboratory information management system for its new genetic testing lab. The system provides automation of all processes while integrating with multiple systems under one umbrella.

Intuitive ecosystem for lab support, 9/15

Sysmex announced its Beyond a Better Box product and services model to deliver a comprehensive and intuitive ecosystem that aims to add value to laboratory hematology operations through next-generation diagnostics, advanced tools and technologies, process optimization, and harmonized support known as BeyondCare.

Flow cytometry control, 9/15

New products featured by Streck this year included CD-Chex CD103 Plus, a flow cytometry control. It includes CD103, CD30, CD38, CD56, CD138, and cytoplasmic lambda in a single control and provides reference values for CD38. The control includes rare leukemia and lymphoma CD markers that are absent in normal whole blood.